BLUME-JENSEN PETER (President and CEO) sold 0.6% of their position (14.04K shares) of ACRIVON THERAPEUTICS, INC. on the open market
Open‑market sale worth $31.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/27/2026ACC: 0000905148-26-003968
DirectorOfficer· President and CEO
Since Mar 2026
-14.04K
Net shares
Net seller
$31.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14.04K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.04K
Price / share
$2.21
Trade value
$30.97K
% of position
0.6%
8/25/2026
2.24M→2.23M
Total
Net shares
−14.04K
Net value
-$30.97K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2026 | S · Sale | −14.04K | $2.21 | $30.97K | 0.6% | 2.24M | 2.23M |
| Total | −14.04K | -$30.97K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned385.86K
Total
385.86K indirect385.86K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 385.86K | Indirect |
| Total | 385.86K | 385.86K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported